LifeStance Health Group, Inc.
LFST
$5.49
$0.091.67%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 83.71% | 103.36% | 84.18% | 90.33% | 48.82% |
Total Depreciation and Amortization | -24.70% | -39.04% | -33.96% | -22.97% | -4.76% |
Total Amortization of Deferred Charges | -39.29% | -40.80% | -21.02% | -18.60% | -20.30% |
Total Other Non-Cash Items | -7.74% | 3.42% | 176.38% | -19.91% | -21.92% |
Change in Net Operating Assets | 60.58% | 9.54% | -15.96% | 21.52% | 170.67% |
Cash from Operations | 46.16% | 85.84% | 271.04% | 189.62% | 10,252.07% |
Capital Expenditure | -51.76% | -40.44% | 44.80% | 48.44% | 55.88% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -51.76% | -40.44% | 44.80% | 48.44% | 55.88% |
Total Debt Issued | -- | -- | 778.73% | -- | -- |
Total Debt Repaid | -147.54% | -148.02% | -44,168.10% | -12.81% | -24.70% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -260.82% | -7.74% | 35.60% |
Cash from Financing | -43.02% | -310.32% | -113.16% | -9.52% | -106.14% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 45.51% | 31.11% | 43.45% | 142.29% | 231.69% |